T/CHATA 027-2022 Active Group standards

T/CHATA 027-2022 Guidelines for the use of fixed-dose combination anti-tuberculosis drugs

T/CHATA 027-2022 Guidelines for the use of fixed-dose combination anti-tuberculosis drugs

Publish Date: 1970-01-01 Implement Date: 1970-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 31.00
Out of stock

Basic Information

Standard Code: T/CHATA 027-2022
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: -
Publish Date: 1970-01-01
Implement Date: 1970-01-01

Scope

This document specifies the dosage specifications, target users, treatment regimens, dosage and usage, clinical manifestations of adverse drug reactions and drug determination of fixed-dose combination anti-tuberculosis drugs, adjustment of anti-tuberculosis treatment regimens, and drug use management and evaluation. This document is applicable to the anti-tuberculosis treatment of tuberculosis patients diagnosed by all levels and types of medical and health institutions, as well as the preventive treatment with anti-tuberculosis drugs for latent tuberculosis infection patients.

Development Information

Word Count: 14 Thousand words

Related Standards

Contact Us